Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Irena Ciećko-Michalska is active.

Publication


Featured researches published by Irena Ciećko-Michalska.


Gastroenterology Research and Practice | 2012

Pathogenesis of Hepatic Encephalopathy

Irena Ciećko-Michalska; Małgorzata Szczepanek; Agnieszka Slowik; Tomasz Mach

Hepatic encephalopathy can be a serious complication of acute liver failure and chronic liver diseases, predominantly liver cirrhosis. Hyperammonemia plays the most important role in the pathogenesis of hepatic encephalopathy. The brain-blood barrier disturbances, changes in neurotransmission, neuroinflammation, oxidative stress, GABA-ergic or benzodiazepine pathway abnormalities, manganese neurotoxicity, brain energetic disturbances, and brain blood flow abnormalities are considered to be involved in the development of hepatic encephalopathy. The influence of small intestine bacterial overgrowth (SIBO) on the induction of minimal hepatic encephalopathy is recently emphasized. The aim of this paper is to present the current views on the pathogenesis of hepatic encephalopathy.


Medical Science Monitor | 2013

Cognitive functions in patients with liver cirrhosis: A tendency to commit more memory errors

Irena Ciećko-Michalska; Jan Wójcik; Magdalena Senderecka; Miroslaw Wyczesany; Marek Binder; Jakub Szewczyk; Tomasz Dziedzic; Agnieszka Slowik; Tomasz Mach

Background Minimal hepatic encephalopathy (MHE) is the mildest form of hepatic encephalopathy (HE). For diagnostic purposes, 2 alternative batteries of psychometric screening tests are recommended. They differ from each other in terms of the cognitive domains assessed. The research was designed to provide a profile of cognitive functioning in patients with liver cirrhosis, using an assessment that covers a wider range of cognitive functions than the usual screening battery. Material/Methods We examined 138 persons, including 88 with liver cirrhosis and 50 healthy volunteers. The Mini Mental State Examination (MMSE) was used for screening and excluding advanced cognitive impairment. Then, to assess cognitive functions in more detail, the following tests were used: Auditory Verbal Learning Test (AVLT), Letter and Semantic Fluency Tests (LF and SF), Trail Making Test (TMT A&B), Digit Symbol Test (DST), Block Design Test (BDT), and Mental Rotation Test (MRT). The MRT task has not been used in MHE diagnosis so far. Finally, 57 patients and 48 controls took part in the entire study. Results Patients with liver cirrhosis commit significantly more errors of intrusions in the AVLT during the delayed free recall trial. Results significantly deviating from the norm in at least 2 tests were found only in 7 cirrhosis patients. Conclusions The results do not provide any specific profile of cognitive disturbances in MHE, but suggest that cirrhosis patients have a tendency to commit more memory errors, probably due to subtle impairments of executive function.


World Journal of Gastroenterology | 2012

Intrahepatic expression of genes related to metabotropic receptors in chronic hepatitis.

Andrzej Cieśla; Maciej Kuśmider; Agata Faron-Górecka; Marta Dziedzicka-Wasylewska; Monika Bociąga-Jasik; Danuta Owczarek; Irena Ciećko-Michalska; Dorota Cibor; Tomasz Mach

AIM To screen for genes related to metabotropic receptors that might be involved in the development of chronic hepatitis. METHODS Assessment of 20 genes associated with metabotropic receptors was performed in liver specimens obtained by punch biopsy from 12 patients with autoimmune and chronic hepatitis type B and C. For this purpose, a microarray with low integrity grade and with oligonucleotide DNA probes complementary to target transcripts was used. Evaluation of gene expression was performed in relation to transcript level, correlation between samples and grouping of clinical parameters used in chronic hepatitis assessment. Clinical markers of chronic hepatitis included alanine and aspartate aminotransferase, γ-glutamyltranspeptidase, alkaline phosphatase and cholinesterase activity, levels of iron ions, total cholesterol, triglycerides, albumin, glucose, hemoglobin, platelets, histological analysis of inflammatory and necrotic status, fibrosis according to METAVIR score, steatosis, as well as anthropometric body mass index, waist/hip index, percentage of adipose tissue and liver size in ultrasound examination. Gender, age, concomitant diseases and drugs were also taken into account. Validation of oligonucleotide microarray gene expression results was done with the use of quantitative real-time polymerase chain reaction (qRT-PCR). RESULTS The highest (0.002 < P < 0.046) expression among genes encoding main components of metabotropic receptor pathways, such as the α subunit of G-coupled protein, phosphoinositol-dependent protein kinase or arrestin was comparable to that of angiotensinogen synthesized in the liver. Carcinogenesis suppressor genes, such as chemokine ligand 4, transcription factor early growth response protein 1 and lysophosphatidic acid receptor, were characterized by the lowest expression (0.002 < P < 0.046), while the factor potentially triggering hepatic cancer, transcription factor JUN-B, had a 20-fold higher expression. The correlation between expression of genes of protein kinases PDPK1, phosphoinositide 3-kinase and protein kinase A (Spearmans coefficient range: 0.762-0.769) confirmed a functional link between these enzymes. Gender (P = 0.0046) and inflammation severity, measured by alanine aminotransferase activity (P = 0.035), were characterized by diverse metabotropic receptor gene expression patterns. The Pearsons coefficient ranging from -0.35 to 0.99 from the results of qRT-PCR and microarray indicated that qRT-PCR had certain limitations as a validation tool for oligonucleotide microarray studies. CONCLUSION A microarray-based analysis of hepatocyte metabotropic G-protein-related gene expression can reveal the molecular basis of chronic hepatitis.


Postȩpy higieny i medycyny doświadczalnej | 2014

TGF-β1 and granulocyte elastase in the evaluation of activity of inflammatory bowel disease. A pilot study.

Irena Ciećko-Michalska; Iga Wierzbicka-Tutka; Małgorzata Szczepanek; Danuta Fedak; Konrad Jabłoński; Dorota Cibor; Tomasz Mach

INTRODUCTION The aim was to assess the usefulness of TGF-β1 and elastase in the evaluation of activity of ulcerative colitis (UC) and Crohns disease (CD). MATERIAL AND METHODS 32 patients diagnosed with UC, 31 with CD and 30 healthy volunteers were enrolled in this study. Diagnosis of the disease was confirmed by videocolonoscopy and histopathological evaluation of intestinal biopsies. Disease activity was assessed by use of the Mayo Scoring System for Assessment of Ulcerative Colitis Activity in UC patients and by CDAI in CD patients. hsCRP was determined by the immunonephelometric method, TGF-β1 and elastase plasma concentration by ELISA. The results of the study were analyzed using Statistica and R statistical language. RESULTS In UC a positive correlation between disease activity and platelet level, hsCRP and TGF-β1 concentration was noted. Elastase concentration in UC patients was significantly higher than in CD, but there was no correlation with the activity of the disease. In CD patients we observed a positive correlation between disease activity and leukocytes, platelet levels and elastase concentration, and a very low correlation with hsCRP and TGF-β1. DISCUSSION Determination of TGF-β1 can be used for evaluation of inflammatory activity in UC and it is connected with elevated concentrations of CRP and platelets. To a lower extent TGF-β1 can also be used for evaluation of inflammatory activity in CD. Examination of elastase concentration may be useful in the assessment of CD activity. Plasma elastase concentration may be helpful in UC and CD differentiation. The preliminary results of this investigation seem promising; nevertheless, more studies are necessary.


Journal of Physiology and Pharmacology | 2012

COGNITIVE EVOKED RESPONSE POTENTIALS IN PATIENTS WITH LIVER CIRRHOSIS WITHOUT DIAGNOSIS OF MINIMAL OR OVERT HEPATIC ENCEPHALOPATHY. A PILOT STUDY

Irena Ciećko-Michalska; Jan Wójcik; Miroslaw Wyczesany; Marek Binder; Jakub Szewczyk; Magdalena Senderecka; Tomasz Dziedzic; Agnieszka Slowik; Tomasz Mach


Polskie Archiwum Medycyny Wewnetrznej-polish Archives of Internal Medicine | 2011

Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b.

Tomasz Mach; Andrzej Cieśla; Wioleta Warunek; Urszula Janas-Skulina; Dorota Cibor; Danuta Owczarek; Irena Ciećko-Michalska


Advances in Medical Sciences | 2006

Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis

Irena Ciećko-Michalska; Magdalena Senderecka; Jakub Szewczyk; Panasiuk A; Agnieszka Slowik; Miroslaw Wyczesany; Marek Binder; Tomasz Mach


Neurologia I Neurochirurgia Polska | 2013

The β-fibrinogen –455G/A gene polymorphism and the risk of ischaemic stroke in a Polish population

Aleksandra Golenia; Joanna Chrzanowska-Wasko; Jeremiasz M. Jagiella; Marcin Wnuk; Antoni Ferens; Aleksandra Klimkowicz-Mrowiec; Mateusz G. Adamski; Irena Ciećko-Michalska; Agnieszka Slowik


Gastroenterology Review | 2012

The importance of IL28B polymorphism in response to pegylated interferon α and ribavirin in chronic hepatitis caused by HCV genotype 1b

Tomasz Mach; Andrzej Cieśla; Marek Sanak; Mikołaj K. Głowacki; Wioleta Warunek; Danuta Owczarek; Irena Ciećko-Michalska


Advances in Medical Sciences | 2006

Optimal maintenance therapy in patients with non-erosive reflux disease reporting mild reflux symptoms - a pilot study

Dorota Cibor; Irena Ciećko-Michalska; Danuta Owczarek; Szczepanek M

Collaboration


Dive into the Irena Ciećko-Michalska's collaboration.

Top Co-Authors

Avatar

Tomasz Mach

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Agnieszka Slowik

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Marek Binder

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tomasz Dziedzic

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Danuta Owczarek

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dorota Cibor

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Jan Wójcik

Jagiellonian University

View shared research outputs
Researchain Logo
Decentralizing Knowledge